MARVELL TECHNOLOGY INC
MRVLNASDAQ$246.19▲ $2.58 (+1.06%)
After hours · at closeTrack MRVL
Get earnings, price moves & breaking news on Telegram
24h▲ 1.1%
7d▲ 0.6%
14d▲ 0.3%
30d▼ 2.2%
ytd▲ 189.7%
1y▲ 178.4%
🏦Market Cap
$215.88B
Large Cap
📈Revenue Growth (YoY)
30.6%
High Growth
📊Gross Margin
52.2%
Healthy
💵FCF Margin
18.2%
Healthy
⚖️P/S Ratio
21.7x
Expensive
Otter Score
56
Fair
MARVELL TECHNOLOGY INC
MRVLAnalyst Ratings
Price
$246.19
Total
74
Raised
13
Lowered
4
Avg PT
$327.86
H / L
$450 / $190
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Stifel | Reiterated | Buy | 2026-10-07 | — | — |
RBC Capital | Reiterated | Outperform | 2026-10-07 | $425.00 | +72.60% |
Susquehanna | Reiterated | Positive | 2026-10-07 | $340.00 | +38.10% |
UBS | Reiterated | Buy | 2026-10-07 | $350.00 | +42.20% |
Needham | Reiterated | Buy | 2026-10-07 | $400.00 | +62.50% |
Wolfe Research | Reiterated | Outperform | 2026-10-07 | $375.00 | +52.30% |
Morgan Stanley | Reiterated | Equal Weight | 2026-10-07 | $300.00 | +21.90% |
Evercore ISI Group | Reiterated | Outperform | 2026-10-07 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-10-07 | $400.00 | +62.50% |
JP Morgan | Reiterated | Overweight | 2026-10-07 | — | — |
StoneX | Reiterated | Buy | 2026-10-07 | — | — |
Cantor Fitzgerald | Reiterated | Neutral | 2026-10-07 | $350.00 | +42.20% |
TD Cowen | Upgraded | Hold → Buy | 2026-10-07 | — | — |
Jefferies | Reiterated | Buy | 2026-10-07 | $450.00 | +82.80% |
Wells Fargo | Reiterated | Overweight | 2026-10-07 | $365.00 | +48.30% |
B. Riley Securities | Reiterated | Buy | 2026-08-28 | — | — |
Craig-Hallum | Reiterated | Buy | 2026-08-28 | $380.00 | +54.40% |
Oppenheimer | Reiterated | Outperform | 2026-08-28 | $425.00 | +72.60% |
Rosenblatt | Reiterated | Buy | 2026-08-28 | — | — |
Citigroup | Reiterated | Buy | 2026-08-21 | — | — |
BMO Capital | Reiterated | Outperform | 2026-08-21 | $325.00 | +32.00% |
Keybanc | Reiterated | Overweight | 2026-07-14 | $400.00 | +62.50% |
B of A Securities | Reiterated | Buy | 2026-06-23 | — | — |
Barclays | Reiterated | Overweight | 2026-05-29 | $275.00 | +11.70% |
Benchmark | Reiterated | Buy | 2026-05-28 | — | — |
Roth Capital | Reiterated | Buy | 2026-05-28 | $350.00 | +42.20% |
HSBC | Upgraded | Hold → Buy | 2026-05-26 | $300.00 | +21.90% |
KGI Securities | Upgraded | Neutral → Outperform | 2026-03-06 | — | — |
Melius Research | Upgraded | Hold → Buy | 2026-01-05 | $220.00 | −10.60% |
Goldman Sachs | Reiterated | Neutral | 2025-12-03 | $270.00 | +9.70% |
Deutsche Bank | Reiterated | Buy | 2025-12-03 | $240.00 | −2.50% |
Raymond James | Reiterated | Outperform | 2025-05-30 | $295.00 | +19.80% |
Loop Capital | Reiterated | Buy | 2025-05-30 | — | — |
Roth MKM | Reiterated | Buy | 2024-04-12 | — | — |
Argus Research | Reiterated | Buy | 2024-03-12 | — | — |
Summit Insights Group | Upgraded | Hold → Buy | 2024-03-08 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-03-03 | — | — |
Exane BNP Paribas | Reiterated | Outperform | 2022-09-13 | — | — |
Cowen & Co. | Reiterated | Outperform | 2022-05-27 | $200.00 | −18.80% |
B. Riley FBR | Reiterated | Buy | 2020-05-29 | — | — |
CFRA | Reiterated | Buy | 2020-05-29 | — | — |
SMBC Nikko | Reiterated | Outperform | 2020-02-11 | — | — |
William Blair | Reiterated | Outperform | 2019-07-15 | — | — |
Citi | Reiterated | Buy | 2019-05-31 | — | — |
MKM Partners | Reiterated | Buy | 2019-05-31 | — | — |
Bank of America | Reiterated | Buy | 2019-04-17 | — | — |
Macquarie | Upgraded | Neutral → Outperform | 2019-02-19 | — | — |
Stifel Nicolaus | Upgraded | Hold → Buy | 2018-10-12 | $370.00 | +50.30% |
Longbow Research | Reiterated | Buy | 2018-04-18 | — | — |
Argus | Reiterated | Buy | 2018-03-07 | — | — |
PiperJaffray | Reiterated | Overweight | 2017-12-19 | — | — |
KeyBanc | Reiterated | Overweight | 2017-08-25 | $400.00 | +62.50% |
Pacific Crest | Upgraded | Sector Weight → Overweight | 2017-06-20 | — | — |
Stephens & Co. | Reiterated | Overweight | 2016-08-31 | — | — |
Northland Securities | Upgraded | Market Perform → Outperform | 2016-07-28 | — | — |
Brean Capital | Upgraded | Hold → Buy | 2016-04-14 | — | — |
Standpoint Research | Downgraded | Buy → Hold | 2016-04-06 | — | — |
B. Riley | Reiterated | Buy | 2016-02-08 | — | — |
Nomura | Downgraded | Buy → Neutral | 2015-10-12 | — | — |
FBR Capital | Reiterated | Market Perform | 2015-09-28 | — | — |
JMP Securities | Reiterated | Market Underperform | 2015-09-15 | — | — |
Ladenburg Thalmann | Upgraded | Neutral → Buy | 2015-08-19 | — | — |
Williams Financial | Reiterated | Buy | 2013-11-22 | — | — |
Lazard | Upgraded | Neutral → Buy | 2013-07-01 | — | — |
Standpoint | Reiterated | Accumulate → Buy | 2013-03-04 | — | — |
DA Davidson | Reiterated | Buy | 2013-02-22 | $225.00 | −8.60% |
Wunderlich | Reiterated | Hold | 2012-12-28 | — | — |
Williams Capital | Reiterated | Buy | 2012-11-14 | — | — |
BOE Securities | Downgraded | Buy → Hold | 2012-10-24 | — | — |
ACI Research | Upgraded | Sell → Hold | 2012-10-19 | — | — |
ISI Group | Reiterated | Hold | 2012-10-08 | — | — |
Canaccord Genuity | Downgraded | Buy → Hold | 2012-09-26 | — | — |
Auriga | Reiterated | Buy | 2012-02-24 | — | — |
Morgan Keegan | Reiterated | Outperform | 2012-02-24 | — | — |
Institution
Stifel
Reiterated · Buy · 2026-10-07
—
—
RBC Capital
Reiterated · Outperform · 2026-10-07
$425.00
+72.60%
Susquehanna
Reiterated · Positive · 2026-10-07
$340.00
+38.10%
UBS
Reiterated · Buy · 2026-10-07
$350.00
+42.20%
Needham
Reiterated · Buy · 2026-10-07
$400.00
+62.50%
Wolfe Research
Reiterated · Outperform · 2026-10-07
$375.00
+52.30%
Morgan Stanley
Reiterated · Equal Weight · 2026-10-07
$300.00
+21.90%
Evercore ISI Group
Reiterated · Outperform · 2026-10-07
—
—
Piper Sandler
Reiterated · Overweight · 2026-10-07
$400.00
+62.50%
JP Morgan
Reiterated · Overweight · 2026-10-07
—
—
StoneX
Reiterated · Buy · 2026-10-07
—
—
Cantor Fitzgerald
Reiterated · Neutral · 2026-10-07
$350.00
+42.20%
TD Cowen
Upgraded · Hold → Buy · 2026-10-07
—
—
Jefferies
Reiterated · Buy · 2026-10-07
$450.00
+82.80%
Wells Fargo
Reiterated · Overweight · 2026-10-07
$365.00
+48.30%
B. Riley Securities
Reiterated · Buy · 2026-08-28
—
—
Craig-Hallum
Reiterated · Buy · 2026-08-28
$380.00
+54.40%
Oppenheimer
Reiterated · Outperform · 2026-08-28
$425.00
+72.60%
Rosenblatt
Reiterated · Buy · 2026-08-28
—
—
Citigroup
Reiterated · Buy · 2026-08-21
—
—
BMO Capital
Reiterated · Outperform · 2026-08-21
$325.00
+32.00%
Keybanc
Reiterated · Overweight · 2026-07-14
$400.00
+62.50%
B of A Securities
Reiterated · Buy · 2026-06-23
—
—
Barclays
Reiterated · Overweight · 2026-05-29
$275.00
+11.70%
Benchmark
Reiterated · Buy · 2026-05-28
—
—
Roth Capital
Reiterated · Buy · 2026-05-28
$350.00
+42.20%
HSBC
Upgraded · Hold → Buy · 2026-05-26
$300.00
+21.90%
KGI Securities
Upgraded · Neutral → Outperform · 2026-03-06
—
—
Melius Research
Upgraded · Hold → Buy · 2026-01-05
$220.00
−10.60%
Goldman Sachs
Reiterated · Neutral · 2025-12-03
$270.00
+9.70%
Deutsche Bank
Reiterated · Buy · 2025-12-03
$240.00
−2.50%
Raymond James
Reiterated · Outperform · 2025-05-30
$295.00
+19.80%
Loop Capital
Reiterated · Buy · 2025-05-30
—
—
Roth MKM
Reiterated · Buy · 2024-04-12
—
—
Argus Research
Reiterated · Buy · 2024-03-12
—
—
Summit Insights Group
Upgraded · Hold → Buy · 2024-03-08
—
—
Credit Suisse
Reiterated · Outperform · 2023-03-03
—
—
Exane BNP Paribas
Reiterated · Outperform · 2022-09-13
—
—
Cowen & Co.
Reiterated · Outperform · 2022-05-27
$200.00
−18.80%
B. Riley FBR
Reiterated · Buy · 2020-05-29
—
—
CFRA
Reiterated · Buy · 2020-05-29
—
—
SMBC Nikko
Reiterated · Outperform · 2020-02-11
—
—
William Blair
Reiterated · Outperform · 2019-07-15
—
—
Citi
Reiterated · Buy · 2019-05-31
—
—
MKM Partners
Reiterated · Buy · 2019-05-31
—
—
Bank of America
Reiterated · Buy · 2019-04-17
—
—
Macquarie
Upgraded · Neutral → Outperform · 2019-02-19
—
—
Stifel Nicolaus
Upgraded · Hold → Buy · 2018-10-12
$370.00
+50.30%
Longbow Research
Reiterated · Buy · 2018-04-18
—
—
Argus
Reiterated · Buy · 2018-03-07
—
—
PiperJaffray
Reiterated · Overweight · 2017-12-19
—
—
KeyBanc
Reiterated · Overweight · 2017-08-25
$400.00
+62.50%
Pacific Crest
Upgraded · Sector Weight → Overweight · 2017-06-20
—
—
Stephens & Co.
Reiterated · Overweight · 2016-08-31
—
—
Northland Securities
Upgraded · Market Perform → Outperform · 2016-07-28
—
—
Brean Capital
Upgraded · Hold → Buy · 2016-04-14
—
—
Standpoint Research
Downgraded · Buy → Hold · 2016-04-06
—
—
B. Riley
Reiterated · Buy · 2016-02-08
—
—
Nomura
Downgraded · Buy → Neutral · 2015-10-12
—
—
FBR Capital
Reiterated · Market Perform · 2015-09-28
—
—
JMP Securities
Reiterated · Market Underperform · 2015-09-15
—
—
Ladenburg Thalmann
Upgraded · Neutral → Buy · 2015-08-19
—
—
Williams Financial
Reiterated · Buy · 2013-11-22
—
—
Lazard
Upgraded · Neutral → Buy · 2013-07-01
—
—
Standpoint
Reiterated · Accumulate → Buy · 2013-03-04
—
—
DA Davidson
Reiterated · Buy · 2013-02-22
$225.00
−8.60%
Wunderlich
Reiterated · Hold · 2012-12-28
—
—
Williams Capital
Reiterated · Buy · 2012-11-14
—
—
BOE Securities
Downgraded · Buy → Hold · 2012-10-24
—
—
ACI Research
Upgraded · Sell → Hold · 2012-10-19
—
—
ISI Group
Reiterated · Hold · 2012-10-08
—
—
Canaccord Genuity
Downgraded · Buy → Hold · 2012-09-26
—
—
Auriga
Reiterated · Buy · 2012-02-24
—
—
Morgan Keegan
Reiterated · Outperform · 2012-02-24
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space